ÂÜÀòÂÒÂ×

Dr. Lazaridis has held key positions within the pharmaceutical and diagnostic industry for over 20 years and has extensive expertise in regulatory and drug development from a CRO perspective with a focus on pharmaceutical and diagnostic products involving various therapeutic areas. Before forming Accugenomics, Dr. Lazaridis served as President of Gene Express Inc, an emerging diagnostics company. He has also held several key positions within AAI Pharma from 1988 to 2006 and most recently served as Senior Vice President of Pharmaceutical Development at AAI Pharma, where he led a team of professionals in three business units from formulation to commercialization. He was involved in several regulatory approvals and the commercialization of several pharmaceutical products. Dr. Lazaridis received his Ph.D. at NC State University and his Bachelor’s degree in chemistry from Jacksonville State University.